Greater China Digest: GL Ventures co-leads Thousand Oaks round; Taiwan’s Influenxio bags $2m

Thousand Oaks Biopharmaceuticals has raised over 400 million yuan ($61 million) in its Series C round of financing co-led by China State-Owned Capital Venture Investment Fund and GL Ventures, while Taipei-based Influenxio has garnered $2 million from DCM Ventures.

GL co-leads $61m funding in Thousand Oaks

China’s Thousand Oaks Biopharmaceuticals, Inc has bagged over 400 million yuan ($61 million) in its Series C round of financing co-led by China State-Owned Capital Venture Investment Fund and Asia’s PE firm Hillhouse Capital’s venture unit GL Ventures. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter